Enanta Pharmaceuticals Q3 Revenue USD 14.359 Million Vs. IBES Estimate USD 16.8 Million
ENTA•Q3 financial results
Aug. 10 (Reuters) - Enanta Pharmaceuticals Q3 net income was USD -19.501 million.
- Q3 operating expenses: USD 31.595 million
- Q3 pretax profit: USD -19.465 million
- Q3 operating income: USD -17.236 million
